The Indian Council of Medical Research is fast-tracking an experimental RNA-based antiviral therapy for Chikungunya, inviting Indian companies to develop and manufacture it. Developed by ICMR's National Institute of Virology, the therapy showed complete viral suppression in pre-clinical studies by targeting essential viral genes. Read more